SWX

Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair

Retrieved on: 
Wednesday, April 24, 2024
University, Executive, SWX, Harness, GRI, CNS, PTI, Novartis, Therapy, Spondyloarthropathy, Audit committee, Patient, York University, Proteostasis, Growth, Fine chemical

Cambridge, UK, April 24 2024: Harness Therapeutics, a biotechnology company focused on protein upregulation to develop next generation therapeutics for neurodegenerative diseases, today announced the appointment of Ms. Meenu Chhabra Karson as Chair of its Board of Directors.

Key Points: 
  • Cambridge, UK, April 24 2024: Harness Therapeutics, a biotechnology company focused on protein upregulation to develop next generation therapeutics for neurodegenerative diseases, today announced the appointment of Ms. Meenu Chhabra Karson as Chair of its Board of Directors.
  • Ms. Chhabra Karson brings over 20 years of experience in the global biopharmaceutical industry spanning leadership roles in both private and public large pharmaceutical as well as small biotech companies.
  • Since January 2023, Ms. Chhabra Karson has also served on the board of Macrogenics (MGNX) and is a member of its audit committee.
  • Jan Thirkettle, CEO of Harness commented, “I am delighted to welcome Meenu as our new Board Chair.

Galderma Delivers a Strong Start to the Year With Record Net Sales of Over 1 Billion USD for the First Quarter and 12.4% Year-on-Year Growth

Retrieved on: 
Wednesday, April 24, 2024
Cosmetics, Lifestyle, Retail, Health, Consumer, Pharmaceutical, USD, Core, Corporation, FDA, American Academy, Prurigo nodularis, SWX, International, Social, Acne, Super Bowl, Aesthetics, Dermatology, Business ethics, Sustainalytics, Chinese New Year, Neuromodulation, Filler (animal food), Bowl game, IPO, Science, Patient, ESG, AAD, Atopic dermatitis, Growth, Corporate governance, SIX Swiss Exchange, Pharmaceutical industry

Year-on-year net sales growth on a constant currency basis for the period was 12.4%, primarily driven by volume.

Key Points: 
  • Year-on-year net sales growth on a constant currency basis for the period was 12.4%, primarily driven by volume.
  • Injectable Aesthetics net sales for the first quarter of 2024 were 511 million USD, with year-on-year growth of 19.3% on a constant currency basis.
  • Dermatological Skincare net sales for the first quarter of 2024 were 351 million USD, with year-on-year growth of 8.4% on a constant currency basis.
  • Therapeutic Dermatology net sales for the first quarter of 2024 were 209 million USD, with year-on-year growth of 4.1% on a constant currency basis.

SuperWorld Partners with Tilia to Power its Digital Economy

Retrieved on: 
Thursday, November 16, 2023
Payments, Metaverse, Online, Professional Services, Technology, Electronic Games, Fintech, Entertainment, Love, SWX, Multimedia, Commerce, Augmented reality, Sports Illustrated, Map, Advertising, Digital, Partnership, Superworld, Cryptocurrency, Online shopping, Tilia

Owners of SuperWorld virtual real estate can activate monetization from ticket sales, digital commerce, e-commerce, advertising and gaming on their virtual real estate properties.

Key Points: 
  • Owners of SuperWorld virtual real estate can activate monetization from ticket sales, digital commerce, e-commerce, advertising and gaming on their virtual real estate properties.
  • Any user in SuperWorld can explore and create AR content, engage in the virtual real estate marketplace, create and share digital assets that unlock real-world utility or build digital twins of their physical property.
  • “SuperWorld is a gateway for mainstream users to benefit from the power of all the new technologies that are transforming our world.
  • ‘We are pleased to support SuperWorld and their unique business model,” said Brad Oberwager, CEO of Tilia LLC.

Altria Group, Inc. Announces Retirement of Director Nabil Y. Sakkab From Board of Directors

Retrieved on: 
Wednesday, October 25, 2023
Tobacco, Retail, NJOY, FDA, AB InBev, Helix, Horizon, Food, Virginia Tech Corporate Research Center, ABI, Annual general meeting, Chairperson, Corporate governance, Regulation of tobacco by the U.S. Food and Drug Administration, PM, Philip Morris USA Inc. v. Williams, Procter & Gamble, SWX, Social, Marlboro, Euronext Growth, Marketing, John Middleton Co., Retirement, Smoker, Investment, Heated tobacco product, MST, Cronos, Altria

Nabil Y. Sakkab, a director of Altria Group, Inc. (“Altria”) since 2008, will retire from service on our Board of Directors following the completion of his current term.

Key Points: 
  • Nabil Y. Sakkab, a director of Altria Group, Inc. (“Altria”) since 2008, will retire from service on our Board of Directors following the completion of his current term.
  • Consequently, Mr. Sakkab will not stand for re-election to the Board of Directors at Altria’s 2024 Annual Meeting of Shareholders, which Altria anticipates holding on May 16, 2024.
  • "Nabil's contributions have significantly benefited Altria over the past 15 years," said Kathryn McQuade, Altria’s independent Chair of the Board.
  • "We thank him for his long and distinguished service and wish him the very best upon his retirement."

NewGAMe investor group announces candidate for GAM CEO and provides funding of up to CHF 100 million

Retrieved on: 
Tuesday, September 26, 2023
GAM (company), Elmar, Swiss Financial Market Supervisory Authority, SWX, GAM, EGM, Rock, Knowledge, Growth, Julius Baer Group, Letter, CHF, Cryptocurrency, Management

The investor group comprised of NewGAMe SA and Bruellan SA, which controls approximately 9.6% of the issued share capital of GAM Holding AG [GAM:SWX] ("GAM"), announces Elmar Zumbuehl as its proposed candidate for CEO of GAM.

Key Points: 
  • The investor group comprised of NewGAMe SA and Bruellan SA, which controls approximately 9.6% of the issued share capital of GAM Holding AG [GAM:SWX] ("GAM"), announces Elmar Zumbuehl as its proposed candidate for CEO of GAM.
  • Elmar Zumbuehl, a Swiss citizen, joined GAM in 2010 and is currently Chief Risk Officer and a member of the Group Management Board.
  • Rock Investment SAS, a member of the NewGAMe investor group, has already provided short-term financing of up to CHF 20 million to cover GAM’s immediate liquidity needs.
  • We are also thrilled that Elmar has accepted the opportunity to work with the new board as CEO of GAM.

NewGAMe provides update on regulatory filings required to increase GAM shareholding to 20-30%

Retrieved on: 
Monday, September 18, 2023
GAM (company), SWX, GAM, Swiss Financial Market Supervisory Authority, Cryptocurrency

Geneva, 18 September 2023 – The investor group comprised of NewGAMe SA and Bruellan SA, which controls approximately 9.6% of the issued share capital of GAM Holding AG [GAM:SWX] ("GAM") announces that it has submitted all regulatory filings to be authorized to hold between 20% and 30% of GAM.

Key Points: 
  • Geneva, 18 September 2023 – The investor group comprised of NewGAMe SA and Bruellan SA, which controls approximately 9.6% of the issued share capital of GAM Holding AG [GAM:SWX] ("GAM") announces that it has submitted all regulatory filings to be authorized to hold between 20% and 30% of GAM.
  • The investor group has submitted applications to be authorized to hold between 20 and 30% of the issued share capital of GAM to the following authorities:
    -        Swiss Financial Market Supervisory Authority FINMA;
    -        United Kingdom Financial Conduct Authority;
    NewGAMe expects a decision from the relevant regulators in the near future.

NewGAMe investor group welcomes ISS proxy report in favour of all EGM proposals

Retrieved on: 
Monday, September 11, 2023
GAM (company), Chair, Institutional Shareholder Services, ISS, SWX, GAM, EGM, Professional Football Compensation Committee, Compensated emancipation, Security (finance)

Geneva, 11 September 2023 – The investor group comprised of NewGAMe SA and Bruellan SA, which controls approximately 9.6% of the issued share capital of GAM Holding AG [GAM:SWX] ("GAM"), welcomes a new Institutional Shareholder Services (ISS) proxy report in favour of all upcoming EGM shareholder proposals.

Key Points: 
  • Geneva, 11 September 2023 – The investor group comprised of NewGAMe SA and Bruellan SA, which controls approximately 9.6% of the issued share capital of GAM Holding AG [GAM:SWX] ("GAM"), welcomes a new Institutional Shareholder Services (ISS) proxy report in favour of all upcoming EGM shareholder proposals.
  • ISS’s proxy research report, published on 8 September 2023, is in favour of all shareholder proposals submitted by NewGAMe for the 27 September 2023 EGM.
  • Antoine Spillmann, CEO and Partner at Bruellan and proposed candidate for Chair of GAM said:
    “We are delighted that ISS has recommended GAM shareholders vote in favour of all of the EGM proposals submitted by our investor group.
  • We are committed to our turnaround plan and ensuring a successful future for GAM that creates long-term value for all stakeholders.”

NewGAMe investor group welcomes GAM board approval for EGM proposals and reiterates its long-term support for the company

Retrieved on: 
Wednesday, September 6, 2023
Swiss Code of Obligations, GAM (company), Chair, SWX, GAM, EGM, Growth, Professional Football Compensation Committee, Compensated emancipation, Security (finance)

The investor group comprised of NewGAMe SA and Bruellan SA, which controls approximately 9.6% of the issued share capital of GAM Holding AG [GAM:SWX] (“GAM”), reiterates its long-term support for GAM and urges other shareholders to join the current GAM board in voting for the EGM proposals from Rock Investment SAS, a member of the investor group.

Key Points: 
  • The investor group comprised of NewGAMe SA and Bruellan SA, which controls approximately 9.6% of the issued share capital of GAM Holding AG [GAM:SWX] (“GAM”), reiterates its long-term support for GAM and urges other shareholders to join the current GAM board in voting for the EGM proposals from Rock Investment SAS, a member of the investor group.
  • The nominees for election are: Antoine Spillmann, as Chair; and Carlos Esteve, Anthony Maarek, Fabien Pictet and Jeremy Smouha as members of the GAM board.
  • Once the proposals are passed, the new GAM board will take steps to adjust the board representation to meet the requirements of the Swiss Code.
  • We are delighted that Jeremy Smouha has agreed to be a candidate for GAM’s board at the forthcoming EGM.

The Swiss Takeover Board rules on NewGAMe's partial offer for GAM shares

Retrieved on: 
Thursday, August 31, 2023
GAM (company), Prospectus, SWX, Rock, GAM, Swiss Financial Market Supervisory Authority, Cryptocurrency

Geneva, 31 August 2023 – The investor group comprised of NewGAMe SA and Bruellan SA, which controls approximately 9.6% of the issued share capital of GAM Holding AG [GAM:SWX] ("GAM") welcomes the decision of the Swiss Takeover Board ("TOB") on the investor group's partial offer for up to 28 million GAM shares.

Key Points: 
  • Geneva, 31 August 2023 – The investor group comprised of NewGAMe SA and Bruellan SA, which controls approximately 9.6% of the issued share capital of GAM Holding AG [GAM:SWX] ("GAM") welcomes the decision of the Swiss Takeover Board ("TOB") on the investor group's partial offer for up to 28 million GAM shares.
  • NewGAMe will publish this supplementary information in the coming days.
  • In its decision, the TOB challenged the validity of one of the partial offer's conditions (namely the condition making NewGAMe's partial offer subject to Rock's candidates having been elected to GAM's board at an upcoming general meeting of the company).
  • NewGAMe is reviewing the TOB's decision on this point and has five trading days to appeal the decision before the Swiss Financial Market Supervisory Authority FINMA.

NewGAMe investor group names industry veteran as GAM CEO candidate

Retrieved on: 
Wednesday, August 30, 2023
GAM (company), University, CFA, Marketing, Om, Risk management, SWX, GAM, MBA, Loyola University, Fortress Investment Group, BBA, Goldman Sachs, BNP Paribas, Growth, CIO, CAIA, Management, Security (finance), Centaurus

Geneva, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The investor group comprised of NewGAMe SA and Bruellan SA, which controls approximately 9.6% of the issued share capital of GAM Holding AG [GAM:SWX] (“GAM”), has named Randel (“Randy”) Freeman as its candidate for Chief Executive Officer of GAM.

Key Points: 
  • Geneva, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The investor group comprised of NewGAMe SA and Bruellan SA, which controls approximately 9.6% of the issued share capital of GAM Holding AG [GAM:SWX] (“GAM”), has named Randel (“Randy”) Freeman as its candidate for Chief Executive Officer of GAM.
  • Mr Freeman began his career in Europe in 1995 co-managing an internal hedge fund group at Banque Paribas.
  • In 2000, he and his partner spun it out to create Centaurus Capital, one of the first hedge funds in Europe.
  • Antoine Spillmann, CEO and Partner at Bruellan and the investor group's proposed candidate for chairman of GAM's board, said:
    "We are delighted Randy Freeman has agreed to be our candidate for CEO of GAM.